首页> 外文OA文献 >PND71 - A COST MINIMISATION ANALYSIS OF CLADRIBINE TABLETS VERSUS ALTERNATIVE HIGH EFFICACY TREATMENTS FOR RELAPSING MULTIPLE SCLEROSIS (RMS) IN THE UNIED KINGDOM.

【2h】

PND71 - A COST MINIMISATION ANALYSIS OF CLADRIBINE TABLETS VERSUS ALTERNATIVE HIGH EFFICACY TREATMENTS FOR RELAPSING MULTIPLE SCLEROSIS (RMS) IN THE UNIED KINGDOM.

机译：PND71 - 一种克拉酮药片的成本最小化分析与联合王国复发多发性硬化症（RMS）的替代高疗效治疗。

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
G Harty; C Treharne; S Budhia; SL Wong;
展开▼
作者单位

展开▼
年度 2018
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Estimating the comparative efficacy of cladribine tablets versus alternative disease modifying treatments in active relapsing-remitting multiple sclerosis: adjusting for patient characteristics using meta-regression and matching-adjusted indirect treatment comparison approaches [J] . Berardi Andrea, Siddiqui Mohd Kashif, Treharne Catrin, Current medical research and opinion . 2019,第8期

机译：估计克拉酮片剂与替代疾病修饰治疗的对比疗效在活性复发型多发性硬化症中：使用元回归调整患者特征和匹配调整的间接治疗比较方法
2. Systematic literature review and network meta-analysis of cladribine tablets versus alternative disease-modifying treatments for relapsing-remitting multiple sclerosis [J] . Siddiqui Mohd Kashif, Khurana Inderpreet Singh, Budhia Sangeeta, Current medical research and opinion . 2018,第8期

机译：系统文献综述和网络荟萃分析的克拉替宾片与替代疾病改性治疗，用于复发 - 延长多发性硬化症
3. Efficacy of cladribine tablets 3.5 mg/kg in high disease activity (HDA) subgroups of patients with relapsing multiple sclerosis (RMS) in the CLARITY study [J] . Giovannoni Gavin, Rammohan Kottil, Cook Stuart, Multiple sclerosis: clinical and laboratory research . 2018,第2期

机译：在清晰研究中复发多发性硬化症（RMS）的患者的高疾病活动（HDA）亚组中的克拉酮药片3.5mg / kg的疗效
4. Microstructural Modulations in the Hippocampus Allow to Characterizing Relapsing-Remitting Versus Primary Progressive Multiple Sclerosis [C] . Lorenza Brusini, Ilaria Boscolo Galazzo, Muge Akinci, International Workshop on Brain-Lesion;Medical Image Computing and Computer Assisted Intervention Conference . 2020

机译：海马中的微观结构调制允许表征复发 - 延长与初级进步多发性硬化
5. Cost-Effectiveness of Oral Agents in Relapsing-Remitting Multiple Sclerosis Compared to Interferon-Based Therapy in Saudi Arabia [D] . Alskaabi, May. 2017

机译：沙特阿拉伯口服药物在复发缓解型多发性硬化症中的成本效果与基于干扰素的疗法相比
6. Efficacy of Cladribine Tablets in high disease activity subgroups of patients with relapsing multiple sclerosis: A post hoc analysis of the CLARITY study [O] . Gavin Giovannoni, Per Soelberg Sorensen, Stuart Cook, -1

机译：克拉屈滨片对复发性多发性硬化症患者高疾病活动性亚组的疗效：CLARITY研究的事后分析
7. PND28 - A BUDGET IMPACT ANALYSIS OF CLADRIBINE TABLETS VERSUS ALTERNATIVE HIGH EFFICACY TREATMENTS FOR RELAPSING MULTIPLE SCLEROSIS (RMS) IN THE UNITED KINGDOM. [O] . G Harty, C Treharne, S Budhia, 2018

机译：PND28 - 克拉酮药片与替代高疗效治疗的预算影响分析，用于在英国复发多发性硬化症（RMS）。

PND71 - A COST MINIMISATION ANALYSIS OF CLADRIBINE TABLETS VERSUS ALTERNATIVE HIGH EFFICACY TREATMENTS FOR RELAPSING MULTIPLE SCLEROSIS (RMS) IN THE UNIED KINGDOM.

著录项

引文网络

相似文献

相关主题

期刊订阅